Pulmonary Tumors Flashcards
Lung Tumors
Overview
- Bonchogenic carcinoma ⇒ 90-95% of primary lung tumors
- 5% are carcinoids
- Rest are misc. neoplasms including hamartoma
- Benign lung tumors rare
Lung Tumor
Epidemiology
-
Bronchogenic carcinoma
- Most common visceral malignancy
- Most common cause of cancer death worldwide
- US in 2012
- 226k new cases of lung CA
- 14% of new cancer dx
- 160k deaths d/t lung CA
- 8% of all cancer deaths
- 226k new cases of lung CA
- Since 1987, more women die of lung CA than breast CA
- Peak incidence in 6th and 7th decades
Lung Carcinoma
Etiology
-
Cigarette smoking ⇒ #1
- 40 pk-yr hx ⇒ 60x lung CA risk
- 80% of lung CA occurs in smokers or those who recently quit
- Only 11% of heavy smokers get lung CA
- Cessation of smoking for 10 years ↓ risk but never to control levels
-
10-15% of US lung CA occurs in never smokers
- Usu. adenocarcinomas in ♀
- Ionizing radiation
-
Asbestos
- Just asbestos ⇒ 5x risk
- Asbestos + smoking ⇒ 55x risk
- Air pollution ⇒ 2nd hand smoke, Radon
Precursor Lesions
4 types of precursor lesions for lung carcinoma:
- Atypical adenomatous hyperplasia
- Adenocarcinoma in situ
- Squamous dysplasia and carcinoma in situ
- Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
Not all precursor lesions will progress to invasive cancer.
Atypical Adenomatous Hyperplasia
Subtle focal thickening of lung parenchyma and hyperplasia of glandular epithelium
Adenocarcinoma In-situ
Proliferation and tufting of glandular epithelium with cellular atypia.
Does not invade into alveolar wall.
Can become invasive adenocarcinoma if process continues.
Squamous Dysplasia and Carcinoma In-situ
1st step ⇒ metaplasia of normal respiratory epithelium into squamous epithelium
2nd step ⇒ dysplasia of metaplastic sqamous epithelium, can be full thickness but does not invade down through BM
Cells can invade through BM and become Invasive Squamous Cell Carcinoma.
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia
Can become small cell carcinoma
Squamous Cell Carcinoma
Epidemiology
- 20% of lung CA
- Mostly in men
- Strong association with smoking
Squamous Cell Carcinoma
Pathogenesis
-
Usu. centrally located near hilus
- Increasingly becoming more peripheral
-
Metaplasia ⇒ dysplasia ⇒ growth & thickening by local spread ⇒ erosion of epithelial airway lining ⇒ invasion
- Metastasizes later than most other patterns
- Once invasive it can:
-
Form an intraluminal mass
- Can lead to post-obstructive PNA
- Penetrate bronchial wall and infiltrate into carina or mediastinum
- Grow into lung parenchyma
-
Form an intraluminal mass
Squamous Cell Carcinoma
Histology
- Low grade tumors
- Keratinization ⇒ squamous pearls or individual cells w/ eosinophilic, dense cytoplasm
- Intercellular bridges
- ± Central cavitation
Adenocarcinoma
Epidemiology
-
38% of lung CA
-
↑ incidence last 20 years
- May be due to cigarettes making smokers inhaler more deeply
- Expose peripheral airways where adenocarcinoma tends to form
-
↑ incidence last 20 years
-
Most common form in women
- ↑ women smokers
Adenocarcinoma
Pathogenesis
- Most located peripherally
- Starts in mucus-producing glandular cells
- Grows in various patterns
- Acinar
- Lepidic
- Papillary / micropapillary
- Mucinous
- Microinvasive
- Tumors grow more slowly
- Usually smaller than squamous carcinomas
-
Variable glandular differentiation
- May see mucin
-
Tends to metastasize more widely & earlier than squamous carcinomas
- Spread to pleura, regional LN, vessels
Adenocarcinoma
Acinar Pattern
Gland structure clearly visible.
Adenocarcinoma
Lepidic Pattern
Malignant cells grow along alveolar walls.
Adenocarcinoma
Mucinous Pattern
Satellite lesions.
Can resemble PNA.
Microinvasive
Adenocarcinoma
Tumor less than 3 cm.
Invasive component less than 5 mm.
Adenocarcinoma
Molecular Testing
Helps to determine treatment and prognosis for non-small cell lung cancers, esp. adenocarcinoma.
- Test each case of adenocarcinoma
-
EGFR mutations or other tyrosine kinases
- Targeted treatment w/ specific inhibitors
- Prolonged survival
-
Activating KRAS mutations ⇒ ~ 30%
- Associated w/ worse prognosis
-
EGFR mutations or other tyrosine kinases